Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02019927 · ClinicalTrials.gov registry record · NA
Electric Stimulation of the Eye to Improve Vision After Trauma
A NA study, sponsored by Wills Eye.
- Completed
- Registry status
- NA
- Development phase
- 97
- Enrollment target
NCT02019927 is a NA study that has completed, run by Wills Eye. The registered enrollment target is 97 participants.
The verdict
NCT02019927, a NA study, has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- NA
- Development phase
- 97 participants
- Enrollment target
Study Summary
Transcorneal Electrical Stimulation (TES) using the "OkuStim®" device delivers electrical impulses to damaged and/or diseased photoreceptor cells. This electric stimulation of the retina may help to preserve visual acuity and/or the visual field.
Interventions
- DEVICE Sham
- DEVICE Transcorneal Electrical Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2013-07 |
| Est. Completion | 2017-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02019927
The ClinicalTrials.gov registry entry for NCT02019927 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT02019927 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02019927 about?
NCT02019927 is a clinical study titled "Electric Stimulation of the Eye to Improve Vision After Trauma". Transcorneal Electrical Stimulation (TES) using the "OkuStim®" device delivers electrical impulses to damaged and/or diseased photoreceptor cells. This electric stimulation of the retina may help to preserve visual acuity and/or the visual field.
What is the current status of trial NCT02019927?
This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2013-07. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02019927?
The interventions under investigation include: Sham (DEVICE), Transcorneal Electrical Stimulation (DEVICE).
Who is sponsoring clinical trial NCT02019927?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.